A Stocktwits user expressed optimism for the stock, citing the three upcoming FDA applications. Another noted that the low cash reserve is expected in a company not selling products yet.

Ocugen (OCGN) is climbing 5% after investment bank H.C. Wainwright raised its price target on the shares to $8 from $7. OCGN, whose stock is currently trading around 69 cents, develops gene ...

Ocugen, Inc. OCGN was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

StockTwits is unveiling a new feature called Conversations, which should make it easier to not just track the online discussion about a stock, but to join in, too. Co-founder and CEO Howard ...

Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and ...

Ocugen, Inc. OCGN was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal ...